Viriom Inc. is a commercial and late development stage biotech company developing novel therapies and prevention treatments against HIV and hepatitis B virus (HBV). Viriom's pipeline includes: Elpida® (elsulfavirine), the best-in-class NNRTI that received its first market authorization in 2017; fixed doze combinations with nucleoside reverse transcriptase inhibitors; an innovative extended release weekly oral formulation; and VM1500A - a long acting injectable therapy and pre-exposure prophylaxis. Viriom is also developing a highly potent prodrug of the antiviral tenofovir (active component of both Vemlidy® and Viread®) to treat HIV and hepatitis B patients. Viriom believes its drug candidates are capable of achieving breakthroughs in treatment and prevention of HIV and chronic HBV infections in both developing and developed countries.
Company Details
- Employees
- 8
- Address
- 12760 High Bluff Dr, San Diego,california 92130,united States
- Phone
- +1-858-7944860
- vi****@****iom.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- viriom.com
- HQ
- San Diego, California
Viriom Inc Questions
Viriom Inc's helpline number is +1-858-7944860
Viriom Inc's website is viriom.com
Viriom Inc's LinkedIn profile is https://www.linkedin.com/company/viriom-inc
Viriom Inc has
8 employees.
View email and phone details for 8
employees at Viriom Inc.
Viriom Inc's industry is
Pharmaceutical Manufacturing
Viriom Inc's top competitors are
Cardiff Oncology,
Esther Martinborough Consulting,
Arytha Biosciences Llc,
Tracon Pharmaceuticals,
S2s Japan,
Arcellx,
Chemdiv, Inc.,
Eilean Therapeutics,
Trefoil Therapeutics,
Diagenta.
Viriom Inc's support email address is viriom@viriom.com
Viriom Inc's categories are Pharmaceutical Manufacturing
